Warren symposium follows legacy of geneticist giant

If we want to understand how the brain creates memories, and how genetic disorders distort the brain’s machinery, then the fragile X gene is an ideal place to start. That’s why the Stephen T. Warren Memorial Symposium, taking place November 28-29 at Emory, will be a significant event for those interested in neuroscience and genetics. Stephen T. Warren, 1953-2021 Warren, the founding chair of Emory’s Department of Human Genetics, led an international team that discovered Read more

Mutations in V-ATPase proton pump implicated in epilepsy syndrome

Why and how disrupting V-ATPase function leads to epilepsy, researchers are just starting to figure Read more

Tracing the start of COVID-19 in GA

At a time when COVID-19 appears to be receding in much of Georgia, it’s worth revisiting the start of the pandemic in early 2020. Emory virologist Anne Piantadosi and colleagues have a paper in Viral Evolution on the earliest SARS-CoV-2 genetic sequences detected in Georgia. Analyzing relationships between those virus sequences and samples from other states and countries can give us an idea about where the first COVID-19 infections in Georgia came from. We can draw Read more

Georgia

Proton Therapy and Its Importance to Georgia

From Clinic to You

By Walter J. Curran, Jr., MD
Executive Director, Winship Cancer Institute
Chair, Department of Radiation Oncology, Emory University School of Medicine

Walter J. Curran, Jr., MD

Walter J. Curran, Jr., MD

Emory Healthcare is a key player in plans to bring the world’s most advanced radiation treatment for cancer patients to Georgia.  Emory Healthcare has signed a letter of intent with Advanced Particle Therapy, LLC, of Minden, Nevada, opening the door to a final exploratory phase for development of The Georgia Proton Treatment Center – Georgia’s first proton therapy facility.

For certain cancers, proton therapy offers a more precise and aggressive approach to destroying cancerous and non-cancerous tumors, as compared to conventional X-ray radiation. Proton therapy involves the use of a controlled beam of protons to target tumors with precision unavailable in other radiation therapies. According to The National Association for Proton Therapy, the precise delivery of proton energy may limit damage to healthy surrounding tissue, potentially resulting in lower side effects to the patient. This precision also allows for a more effective dose of radiation to be used.

Proton therapy is frequently used in the care of children diagnosed with cancer, as well as in adults who have small, well-defined tumors in organs such as the prostate, brain, head, neck, bladder, lungs, or the spine.  And research is continuing into its efficacy in other cancers.

The gantry, or supporting structure, of a proton therapy machine.

The gantry, or supporting structure, of a proton therapy machine.

The closest proton therapy facility to Georgia is the University of Florida Proton Therapy Institute in Jacksonville.  Currently there are only nine proton therapy centers in the United States, including centers at Massachusetts General Hospital, MD Anderson Cancer Center in Houston and the University of Pennsylvania.

This is an exciting development in our ability to offer not only patients throughout Georgia and the Southeast the widest possible array of treatment options but patients from around the world who can come to Atlanta via the world’s busiest airport, Hartsfield-Jackson International. In addition, we will work to expand its utility and access for patients through collaborative research projects with Georgia Tech and other institutions. Winship physicians will also be able to reach out to their international colleagues and provide direction in how best to study and implement this technology in the care of cancer patients.

Under the letter of intent, Emory Healthcare faculty and staff will provide physician services, medical direction, and other administrative services to the center. Advanced Particle Therapy, through a Special Purpose Company, Georgia Proton Treatment Center, LLC, (GPTC) will design, build, equip and own the center.  The facility, which will be funded by GPTC, will be approximately 100,000 square feet and is expected to cost approximately $200 million.  Site selection for the facility is underway, and pending various approvals, groundbreaking is expected in the Spring of 2012.

Video

The follow video presents a 3D simulation of proton therapy technology.

Additional Information:

Posted on by admin in Uncategorized Leave a comment

March for Babies – March for Hope

As parents we hope all babies are born with a healthy start in life, after a full 37 – 40 weeks in the womb. Sadly, every year more than half a million babies are born prematurely in the United States. The rate of premature birth has risen by 30 percent since 1981 according to the March of Dimes. It’s not clear why some babies are born before full gestation – before their lungs, brains or other organs are fully developed. Thousands don’t live to celebrate their first birthday as a result.

In Georgia more than 400 babies are born too soon each week.  Dr. William Sexson, a neonatologist and professor of pediatrics at Emory University School of Medicine and March of Dimes Prematurity Campaign Chair witnesses the effects of preterm birth every day.  He says, Premature birth is the leading cause of infant mortality. Babies born just a few weeks too soon are at increased risk for newborn health complications, such as breathing problems, can face serious health challenges and are at risk of lifelong disabilities.

On Saturday April 30, 2011, a legion of more than 10,000 families and business leaders from across Georgia will band together for the March of Dimes annual “March for Babies. With more than 30 March for Babies events planned throughout the state, the annual affair is the nation’s oldest walk fundraiser dedicated to preventing premature birth, birth defects and infant mortality. Contact a birth injury medical malpractice attorney if you suspect that a medical staff caused your baby a birth injury.

March for Babies supports research and educational programs aimed at helping women have healthy babies. Funds raised from the March for Babies event will support prenatal wellness programs, critical research and community grants, along with local resources such as the Angel II neonatal transport unit at Grady Memorial Hospital.

Most pregnancies last around 40 weeks. Babies born between 37 and 42 completed weeks of pregnancy are called full term. Babies born before 37 completed weeks of pregnancy are called premature. Women who have hypertension and diabetes are at higher risk to have preterm babies or babies with health problems, says Sexson.

According to the March of Dimes, the most urgent infant health problem in the U.S. today is premature birth. It affects more than half a million babies each year and is the leading cause of newborn death within the first month of life. Last November, the March of Dimes issued a Report Card on Premature Birth, giving the nation a D and Georgia, the grade of F.  Sexson adds, We have a long way to go before all babies in America get a healthy start in life and we are committed to working with state health officials, hospitals and health care providers to continue to fight for preemies.

The March of Dimes is the leading nonprofit organization with its mission to improve the health of babies by preventing birth defects, premature birth and infant mortality.

For more information, or to participate in March for Babies visit marchofdimes.com.

Posted on by admin in Uncategorized Leave a comment

Federal research funding sparks economic growth

A recent report from The Science Coalition gives numerous examples of how federally funded research at universities has led to innovation, new companies, and the creation of jobs. The Sparking Economic Growth report lists the university research origins of 100 companies, including Google, Genentech, Cisco Systems and iRobot. Four Emory startup companies were highlighted among the success stories: GeoVax, Inc., Pharmasset, Inc., Syntermed, Inc., and Triangle Pharmaceuticals, which was later acquired by Gilead Sciences in California.

Emory President James Wagner wrote a followup editorial in the Atlanta Business Chronicle about the importance of scientific research in Georgia’s universities to the health of our economy.

“Atlanta can be proud that Emory University is a shining example in this report, with four highlighted successful companies that were launched because federally funded research resulted in innovative and life-saving discoveries. These four success stories only scratch the surface as examples of the more than 150 companies and the resulting 5,500 jobs created in Georgia from discoveries at its research universities.

“Since the 1990s, Emory has turned external research funding, the majority from the federal government, into more than $775 million in licensing revenues from drugs, diagnostics, devices and consumer products. This is money infused into the state’s economy that helps create jobs and educational opportunities, saves lives, and leads to more research discoveries for the benefit of all. Emory has launched 47 start-up companies and licensed 27 drugs, medical devices and diagnostics already in the marketplace and 12 more currently in human trials.”

GeoVax, Inc., is developing and testing a promising AIDS vaccine based on research at the Emory Vaccine Center and Yerkes National Primate Research Center. Gilead Sciences (from Triangle Pharmaceuticals) and Pharmasset, Inc. are creating AIDS drugs that are taken by over 90 percent of HIV-infected patients in the United States and many more around the world. Syntermed, Inc. distributes imaging software developed at Emory that helps in the diagnosis of more than four million heart disease patients every year.

Posted on by admin in Uncategorized Leave a comment

Program helps South Georgia farmworkers

It’s not often that individuals think about the hard work responsible for the fruits and vegetables for our dinner tables every day. Somehow it magically appears in the produce department season after season, without fail. We don’t have to plant it, water it or pick it. It’s ready for us to take home and prepare.

We never see the thousands of migrant farmworkers who move from county to county during the peak season, providing the growers with the labor required to keep farms bountiful. These men, women and children – unlike the plants they take care of – have no roots and live from day to day wherever they are needed, and until their job is done, says Tom Himelick PA-C, MMSc, founder and director of the South Georgia Farmworker Health Project, and Emory Physician Assistant (PA) Program faculty member and director of community projects.

For most of these workers, having a family health care provider is unthinkable. The combination of poverty, lack of health insurance, language barriers, limited transportation and cultural differences creates a vacuum when it comes to health care.

Read more

Posted on by admin in Uncategorized 1 Comment

Attending to neglected tropical diseases

As Georgia’s immigrant and refugee communities grow, so do Georgia’s cases of infectious tropical diseases. Also known as neglected tropical diseases, these illnesses are endemic in some low-resource countries and cause considerable disability and dysfunction.

Carlos Franco-Paredes, MD, MPH

Carlos Franco-Paredes, MD, MPH

Carlos Franco-Paredes, MD, MPH, a researcher and clinician at the Emory TravelWell Clinic at Emory’s midtown campus, provides pre- and post-travel health care to international travelers, including faculty, staff, students, business travelers and missionaries. Franco-Paredes, an expert in infectious diseases, also treats immigrants and refugees affected by neglected tropical diseases. He and colleagues recently received funding to study the epidemiology and treatment outcomes of tropical infectious diseases in immigrant and refugee communities in Georgia.

With a grant from the Healthcare Georgia Foundation, Franco-Paredes and his colleagues are assessing the prevalence and the outcomes of hepatitis B, Chagas disease and leprosy.

In fact, the clinic is the main referral center for leprosy in the region, and physicians there currently care for about 25 patients with leprosy, a chronic disease. Most of the cases are found in foreign-born individuals, particularly patients from Central and South America and Asia.

Franco-Paredes’ collaborators include Uriel Kitron, PhD, Emory professor and chair, Environmental Studies, and Sam Marie Engle, senior associate director, Emory’s Office of University Community Partnerships.

To hear Franco-Paredes’ own words about his research into neglected tropical diseases, listen to Emory’s Sound Science podcast.

Posted on by admin in Uncategorized Leave a comment